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Abstract
Background: Whether the occurrence of postoperative cognitive dysfunction is a result of the effects of surgery or
anesthesia is under debate. In this study, we investigated the impact of sevoflurane anesthesia on cognitive performance
and cellular mechanisms involved in learning and memory.
Methods: Male C57Bl6/J mice (4–5 months) were exposed to one minimum alveolar concentration sevoflurane for two
hours. After 24 h, cognitive performance of mice was assessed using the modified hole board test. Additionally, we
evaluated hippocampal long-term potentiation and expression levels of different receptor subunits by recording excitatory
postsynaptic field potentials and using the western blot technique, respectively. Non-anesthetized mice served as controls.
Results: In anesthetized mice, neither cognitive performance nor long-term potentiation was impaired 24 h after anesthesia.
Interestingly, sevoflurane anesthesia induced even an improvement of cognitive performance and an elevation of the
expression levels of N-methyl-D-aspartate (NMDA) receptor type 1 and 2B subunits in the hippocampus.
Conclusions: Since NMDA receptor type 1 and 2B subunits play a crucial role in processes related to learning and memory,
we hypothesize that sevoflurane-induced changes in NMDA receptor subunit composition might cause hippocampus-
dependent cognitive improvement. The data of the present study are in favor of a minor role of anesthesia in mediating
postoperative cognitive dysfunction.
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Introduction
Postoperative cognitive dysfunction (POCD) is a decline in
cognitive performance for weeks or months which occurs after
surgery. Although there is general agreement that POCD is likely
to be multifactorial, it remains unclear, whether its occurrence is a
result of anesthesia, surgery or a combination of both [1].
Animal studies investigating the impact of general anesthesia on
memory formation are rather inconsistent, and showed both an
impairment or improvement of cognitive function. Acquisition of
new memory and performance improvement in an already-
learned spatial memory task was impaired in aged rats up to two
weeks after isoflurane/nitrous oxide anesthesia [2,3]. Adult rats
showed an impaired acquisition of new memory only when tested
two days, but not two weeks after isoflurane/nitrous oxide
anesthesia, when spatial memory performance was even improved
[4,5]. When 12-month-old mice were repetitively exposed to
isoflurane, a decrease in cognitive performance was observed,
which did not occur, when the animals were exposed to halothane
[6]. Other studies showed an enhancement of some aspects of
learning and memory, when animals were exposed to low
concentrations of volatile anesthetics [7–9], or when rats where
exposed to isoflurane during fetal stage [10]. We could show
recently, that isoflurane anesthesia improves cognitive perfor-
mance, enhances hippocampal long-term potentiation (LTP) and
modulates the expression levels of N-methyl-D-aspartate (NMDA)
receptor subunits [11].
The molecular mechanisms of the commonly used volatile
anesthetic sevoflurane are still a matter of debate. Sevoflurane
potentiates c-aminobutyric acid type A (GABAA) and glycine
receptor function, and inhibits nicotinic acetylcholine, a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and NMDA
receptor function (for review see: [12]). In hippocampal slice
preparations, sevoflurane depresses synaptic transmission to CA1
pyramidal neurons [13,14] at least in part by an activation of
GABAA receptors [14–16].
LTP is an enhancement of synaptic efficiency upon repetitive
and/or simultaneous stimulation of afferent inputs and represents
an important and well studied form of synaptic plasticity. It has
been shown that volatile [17–19] and intravenous [20,21]
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anesthetics abolish the formation of LTP when applied during the
LTP-inducing stimulus. Since LTP is considered as one of the
major cellular mechanisms that underlies learning and memory
(for review see: [22]), it has been suggested that its blockade might
contribute to POCD [17,23].
There is data, that the occurrence of POCD might be agent-
specific [6,24,25]. However, published data of studies using animal
models investigating the impact of anesthesia on cognitive
performance is largely limited to isoflurane or combined
isoflurane/nitrous oxide. Therefore, in the study at hand, we
investigated the impact of sevoflurane anesthesia on cognitive
performance, synaptic plasticity and expression of neurotransmit-
ter receptors in mice.
Methods
Animals
Male C57Bl6/J mice (Charles River, Sulzfeld, Germany) were
investigated at the age of 4–5 months. All mice were housed
separately under standard laboratory conditions (12:12 h light/
dark cycle, 22uC, 60% humidity) and had free access to tap water
and standard mouse chow. Prior to the investigations, mice were
allowed to habituate to their new surroundings for at least three
weeks after having been transferred from the breeder.
Anesthesia
Mice were placed in an acrylic glass chamber (FiO2 = 0.4;
T= 32uC). In the anesthesia group (sev) the chamber was pre-
flushed with 5.0 vol% sevoflurane to induce anesthesia. After loss
of postural reflexes, the induced animal was removed from the
chamber. The non-anesthetized animals (sham) were replaced in
their home cages after four minutes, whereas the nose of the
anesthetized mouse was put in a continuously flushed chamber
(3 l/min) with a moderately increased pressure (3 mmHg) to
prevent pulmonary atelectasis. There, the mouse spontaneously
breathed one minimum alveolar concentration (MAC) sevoflurane
in air and oxygen (FiO2= 0.5). Heart rate and respiratory
frequency were monitored. Rectal temperature was maintained
between 37–38uC by applying a warming blanket. To avoid
influence of instrumentation on cognitive and behavioral testing,
mice were not cannulated. After two hours of anesthesia, the
animals were replaced in the induction chamber, which was then
flushed with oxygen. After recovery, the mice were returned to
their home cages.
Cognitive testing
The modified hole board test (MHBT), which enables the
investigation of cognitive, exploratory, and motivational param-
eters in rodents [26], was used to assess the cognitive performance
of mice after sevoflurane anesthesia or sham treatment.
The MHBT consists of an opaque grey polyvinyl chloride board
on which ten cylinders (36363 cm) are placed in two lines. The
board (3561861 cm) is placed in the middle of a polyvinyl
chloride box (50650650 cm), thus representing the unprotected
central area of an open field. The outer protected area is divided
into eight quadrants (16616 cm) by white lines. Each cylinder
contains a small piece of almond (0.05 g), which is placed
underneath a grid and, therefore, cannot be removed by the
animals. In addition, each cylinder is flavored with vanilla essence
(dissolved in water 0.02%; Micro-Plus, Stadtoldendorf, Germany),
as mice are attracted to this flavor. Three of the ten cylinders are
marked with white tape and in these, another piece of almond is
placed on top of the grid as a food reward, which can be reached
by the animals. The positions of these marked and baited cylinders
on the board were changed randomly. Mice should learn that only
marked cylinders are baited with food.
According to previous studies [26–28], several cognitive
functions were evaluated. A hole was counted as visited if the
animal poked its nose over the rim of the cylinder. Omission errors
were defined as the number of marked and baited holes, which
were not visited at all during one trial. Wrong choices represents the
number of non-marked holes, which were visited. The time each
animal required for performing the trial (i.e. visiting all three
baited holes; max. 5 min; time trial) indicates cognitive performance
as well as the motivation to perform the test.
Additionally to the assessment of the described cognitive
parameters, the MHBT also allows an investigation of a variety
of behavioral parameters that can be assigned to ethologically
given and previously validated behavioral categories [26–28]. The
number of times the mouse enters the board (board entries) served as
an indicator for anxiety. The number of times the mice crossed the
marked lines per minute (line crossings) was counted and assessed as
an indicator for locomotor activity.
In the experimental set-up, all mice were placed one after the
other on the starting position in the experimental box and were
allowed to explore the box freely for a maximum of five minutes or
until they found and ate all three food rewards. Three days before
anesthesia, each mouse was habituated to the food reward by
receiving pieces of almond in their home cage. The test was
performed on eight consecutive days (D1 to D8). The first
examination took place 24 h (D1) after anesthesia or sham
treatment. Four trials were carried out per day, with one trial
lasting for a maximum of 300 s followed by a minimum of ten
minutes inter-trial interval.
Compared to other cognitive tests, e.g. the Morris water maze
or the radial arm maze, the MHBT provides several advantages
[29]. First, by supplying a highly attractive food-reward, the mice
do not have to be deprived of food or water, which potentially
could induce stress. Furthermore, they are motivated to perform
the test voluntarily, and this also has been shown to avoid test
inherent stress. Second, a variety of behavioral parameters can be
evaluated in addition to cognitive parameters in one session,
allowing for the assessment of altered motivational systems, which
could potentially have an impact on cognitive performance. A
recently published direct comparison showed that the MHBT is at
least not inferior compared to the Morris water maze in assessing
the functional outcome of rats in a model of cerebral ischemia
[30].
Electrophysiology
Sagittal hippocampal brain slices (350 mm thick) were obtained
from mice 24 h after anesthesia or sham treatment. After killing an
animal by cervical dislocation, the brain was rapidly removed and
slices were prepared in ice-cold artificial cerebrospinal fluid
(ACSF) using a vibroslicer (HM 650 V, Microm International,
Walldorf, Germany). Slices were allowed to recover for at least 1 h
before being transferred to the recording chamber which was
continuously perfused with ACSF at a rate of 5 ml/min. The
ACSF contained (in mM): NaCl, 125; KCl, 2.5; NaHCO3, 25;
CaCl2, 2; MgCl2, 1; D-glucose, 25; NaH2PO4, 1.25 (all substances
from Sigma, Deisenhofen, Germany). Saturation with a mixture of
95% O2/5% CO2 (carbogen gas) led to a pH of 7.4. All
experiments were performed at room temperature (22–24uC).
Extracellular recordings of field excitatory postsynaptic potentials
(fEPSPs) were performed in the CA1 stratum radiatum of the
hippocampus using borosilicate glass micropipettes (1–2 MV) filled
with ACSF. Data were recorded with an Axopatch 200B patch-
clamp amplifier, a Digidata 1200 interface (both from Axon
Sevoflurane Anesthesia and Learning and Memory
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Instruments, Foster City, CA), and the LTP Program 2.30d
software [31]. fEPSPs were evoked by electrical stimulation of the
Schaffer collateral/associational commissural pathway with a
bipolar tungsten electrode insulated to the tip (50 mm tip diameter).
Stimuli were delivered at 30 s intervals, and two consecutive
fEPSPs were averaged for noise minimization. The initial slope of
the rising phase of the fEPSP (taken between 20% and 80% of the
peak amplitude) was used as measure of the strength of synaptic
transmission. For baseline recordings, stimulation intensity was set
to a value that evoked a response approximately 25–30% of the
maximal inducible response. After a minimum of 30 min of stable
baseline recordings, a high frequency stimulus (HFS; 100 pulses
delivered at 100 Hz) was applied to the Schaffer collateral/
associational commissural pathway. After HFS, recordings were
made for 40 min without changing the rate or intensity of the
stimulus, and fEPSP slopes were normalized with respect to the
responses recorded during the last 5 min before HFS. LTP,
quantified as percental elevation of fEPSP slopes 36–40 min after
HFS, was compared between brain slices of mice that underwent
sevoflurane anesthesia or sham treatment.
Analysis of Receptor Expression
24 h after anesthesia or sham treatment, mice were killed by
cervical dislocation, decapitated and their brains were rapidly
removed. Brains were immediately frozen on dry ice. Subsequent-
ly, the hippocampus was dissected and kept at 280uC until used
for Western blotting.
The hippocampus of each animal was homogenized in HEPES
buffer containing 1% NP40 and several proteinase inhibitors
(based on [32]), and centrifuged to eliminate cell debris. The
supernatant was used as total protein sample. Protein concentra-
tion was determined with the BioRad DC protein kit (BioRad,
Munich, Germany). Protein samples (25 mg) of each animal
(n = 6 per group) were loaded on 9% SDS–PAGE and transferred
to nitrocellulose (Protran BA85, 45 mm, Schleicher and Schu¨ll,
Dassel, Germany), using a Mini Transfer Cell (BioRad, Munich,
Germany). The membranes were blocked with 5% BSA in TBS
containing 0.1% Tween 20 (TBS-T) and incubated with the
different primary antibodies overnight. The following antibodies
were used for Western blot analysis: NMDAR1, NMDAR2A,
NMDAR2B, GluR1, GluR2/3, GluR4, GluR6/7, a2-GABAA,
and b2-nAChR (all from Millipore, Schwalbach, Germany).
Incubation with the secondary antibody (horseradish peroxidase-
conjugated donkey anti-rabbit antibody, Amersham Buchler,
Braunschweig, Germany) lasted two hours. All antibody incuba-
tions, washes and dilutions were performed in TBS-T. Antibody
detection was performed with the Amersham ECL Western
blotting analysis system according to the manufacturer’s protocol.
ECL signal was exposed to Hyperfilm-ECL (Amersham Buchler,
Braunschweig, Germany). To verify equal loading of protein, the
same nitrocellulose membrane was re-stained and the total
amount of protein of each lane was assessed. Unless stated
otherwise, all chemicals were obtained from Sigma (Deisenhofen,
Germany).
At least three blots were prepared per antibody, which were
analyzed and averaged. Each Western blot comprised the control
and the remaining experimental group. Blot autoradiographs were
quantified by computer-assisted densitometry using the Optimas
image analysis system (BioScan Optimas, Edmonds, WA). All data
are expressed as relative grey values and, for each subunit, the
values for the anesthetized and sham group were determined by
setting the sham group to 100% and calculating the relative
percentages of the anesthetized group. The respective group values
were pooled as mean 6 SEM.
Statistical Analysis
Statistics were performed using SPSS 14.0 for Windows (SPSS
Inc., Chicago, IL). A two-tailed probability value of P,0.05 was
considered as statistically significant. For analysis of cognitive and
behavioral parameters, the data was assessed in a one- or two-
factor ANOVA, respectively. Statistical analysis for electrophysi-
ology was carried out using the Student’s t-test with a level of
P,0.05 required for significance. Averaged values are given as
mean 6 SEM. Western blot data were proven for significance by
comparing the grey values of the anesthetized and non-anesthe-
tized group of each subunit separately using the Student’s t-test.
Normal distribution of data was verified using the Kolmogorov-
Smirnov test.
Ethics Statement
All studies were approved by the Ethical Committee on Animal
Care and Use of the Government of Bavaria, Germany (permit
number: 55.2-1-54-2531-72-05). All efforts were made to mini-
mize animal suffering and to reduce the number of animals used.
Results
Sevoflurane anesthesia improves cognitive performance
in mice
To determine whether sevoflurane anesthesia without surgery
affects learning and memory, various cognitive and behavioral
parameters were studied using the MHBT. In Fig. 1, time trial (A),
omission errors and wrong choices (B), board entries (C) and line crossings
(D) are plotted against time. Substantial learning occurred in all
groups, which could be proven by a one-factor ANOVA of each
curve, showing a significant effect of time on time trial, omission errors,
wrong choices and board entries (all P,0.001). Group comparisons
revealed that, compared to non-anesthetized controls, anesthetized
mice showed better overall cognitive performance (time trial)
beginning on day three, and better degree of learning (omission
errors and wrong choices) beginning on day two. Starting from day six,
anesthetized showed a less anxious behavior (board entries).
Sevoflurane anesthesia does not affect LTP after 24 h
To evaluate the possibility that sevoflurane anesthesia could
affect synaptic plasticity, LTP was studied in hippocampal slices
of anesthetized and non-anesthetized mice one day after
anesthesia or sham treatment. Delivering HFS induced LTP
of fEPSP slopes, which was not significantly different between
slices of anesthetized (sev) or non-anesthetized (sham) mice
(relative fEPSP slopes sev: 149.669.4% (n = 9); sham:
159.569.4% (n = 10; P = 0.48); Fig. 2).
Expression of NMDA receptor subunit type 1 and 2B is
upregulated after sevoflurane anesthesia
Sevoflurane anesthesia might induce adaptational changes in
the expression levels of neurotransmitter receptor subunits. We
used western blotting for profiling the expression levels of the
NMDA receptor type 1, type 2A and type 2B subunits (NR1,
NR2A, and NR2B), subunits of a-amino-3-hydroxy-5-methyl-4-
isoxazole-propionic acid (GluR1, GluR2/3, GluR4), kainate
(GluR6/7), GABAA (a2), and nicotinic acetylcholine (b2) receptors
in hippocampi of anesthetized and non-anesthetized mice (Fig. 3).
In homogenates of the hippocampi of anesthetized mice, we found
an upregulation of the NR1 subunit (153617% of control, n = 11,
P= 0.01) and the NR2B subunit (177631% of control, n = 11,
P= 0.03). The expression levels of the other receptor subtypes did
not change significantly (Fig. 3).
Sevoflurane Anesthesia and Learning and Memory
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Discussion
The aim of the present study was to determine medium-term
effects of sevoflurane anesthesia on cognitive performance, LTP,
and receptor subunit expression in mice. We found that an
anesthesia with sevoflurane, applied at a clinically relevant
concentration, improved cognitive performance, but had no effect
on hippocampal LTP. The improved cognitive performance might
be explained by the elevated expression levels of the NR1 and
NR2B subunits in the hippocampus.
In the present study, we could see an improvement of
hippocampus-dependent cognitive performance in animals that
were anesthetized. This improvement has been observed starting
from day two lasting until the end of the test at day eight.
Additionally, anesthetized animals showed an attenuated anxiety
behavior beginning at day six. Cognitive processes and anxiety are
closely related and interacting processes. Since the attenuated
anxiety developed considerably after the improvement of cogni-
tion, we interpret the reduced anxiety levels as consequence of the
improved cognitive performance. Anesthetic-induced positive [7–
11,33] and negative [2–4,6,34] effects on cognition and memory
formation in rodents have been reported. Obviously, memory
effects of anesthetics in rodents do critically depend on test
environment, age, and time between anesthesia and cognitive
testing. The sevoflurane-induced improvement of cognitive
performance seen in the present study is strictly in line with our
recently published data, that a preceding isoflurane anesthesia
improves cognitive function [11].
Additionally, we could show that sevoflurane anesthesia induces
an elevation of the expression of the NMDA receptor NR1 and
NR2B subunit in the hippocampus 24 h after the anesthesia. An
altered expression of diverse genes in the hippocampus or
amygdala has been shown in rats being anesthetized with
isoflurane/nitrous oxide [35] or isoflurane alone [36]. On the
protein level, it has been shown that desflurane induces an
alteration of several intracellular proteins, which are important for
the endocytosis of neurotransmitter receptors [37].
The NMDA receptor has been shown to be important for
learning and memory [22,38], and a critical role for the NR2B
subunit in processes related to learning and memory has been
shown by a number of studies. Genetic overexpression of the gene
encoding NR2B led to mice with improved learning and memory
in a variety of behavioral tasks [39,40], whereas a hippocampal
NR2B deficit impaired spatial learning [41]. Therefore, the
Figure 1. Mice that underwent a sevoflurane anesthesia showed better cognitive performance. On days one to eight after undergoing a
sevoflurane anesthesia (sev) or sham treatment (sham), cognitive performance and behavorial parameters were assessed using the modified hole
board test, a task in which the animals are trained to search for food rewards hidden in marked cylinders. A: Time that each animal required for
performing the trial plotted against time. B: Number of marked and baited holes, which were not visited at all during one trial (left) and number of
non-marked holes which were visited (right) plotted against time. C: Number of times the mouse enters the board plotted against time. D: Number
of times the mouse crossed the marked lines per minute plotted against time. Each group consisted of 24 animals. Each symbol represents averaged
data from four trials per day. * p,0.05 reveals better cognitive performance (beginning on day three) and better learning (beginning on day two), as
well as an attenuated anxiety-related behavior (beginning on day six) in anesthetized mice.
doi:10.1371/journal.pone.0064732.g001
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described improvement in cognitive function after sevoflurane
anesthesia, which was already detectable in the early phase of
our behavioral testing, might be explained by the upregulation
of the NR1 and NR2B subunits of the NMDA receptor.
However, our experimental conditions do not allow the
conclusion that the retained cognitive improvement is the result
of a permanent up-regulation of NMDA subunits by sevoflur-
ane. A very recent study reports an upregulation of NR1 and
NR2B subunits of the NMDA receptor after 4 h of isoflurane/
nitrous oxide anesthesia in 18-month-old rats, which was
associated with an impaired spatial learning [34]. This
discrepancy to our data can convincingly be explained by the
age-dependent implications of NMDA receptor levels on
memory: In older rats, high NR1 and NR2B levels correlate
with a decline in memory, whereas in younger ones, high NR1
and NR2B correlate with an improvement [42].
There is evidence that an elevation of NR2B subunits results in
enhanced LTP [39]. In the present study, we observed an elevated
expression level of NR2B subunits in hippocampus homogenates
without enhancement of LTP at the CA1 stratum radiatum
synapse. One possible explanation might be that the observed
upregulation of NR2B subunits occurs at synapses different from
CA1 synapses (e.g. CA3, gyrus dentatus). Numerous reports show
an improved cognitive performance and memory formation
accompanied by an enhanced LTP in certain central nervous
system regions (for review see e.g. [43]). However, this correlation
must not necessarily be a general accepted principle (for reviews
see e.g. [44,45]). The lack of an in vitro and in vivo correlation of
memory related processes might be explained by a hippocampus-
specific improvement of cognitive performance due to altered
neuronal activity in all hippocampal regions and/or in connected
brain areas, which is consequently not detectable with recordings
from the CA1 region only. For sevoflurane, a memory enhancing
Figure 2. Long-term potentiation (LTP) in hippocampal brain
slices of anesthetized and sham-treated mice was not differ-
ent. 24 h after sevoflurane anesthesia (sev) or sham treatment (sham),
brain slices of the animals were prepared and hippocampal LTP was
assessed as elevation of field excitatory postsynaptic potential slopes
(fEPSP slopes) after high frequency stimulation (HFS). HFS led to an LTP
of fEPSP slopes, which was not significantly different between the two
groups. Each symbol represents the averaged fEPSP slopes normalized
with respect to the 5 min baseline period before HFS. Insets show fEPSP
recordings before and 40 min after HFS.
doi:10.1371/journal.pone.0064732.g002
Figure 3. Sevoflurane anesthesia induced changes in the expression of N-methyl-D-aspartate (NMDA) receptor subunits in the
hippocampus. Western blot analysis was used to determine the protein expression levels of various receptor subunits in the hippocampi of
anesthetized (sev) and non-anesthetized (sham) mice. Changes in expression levels in the sev group are expressed as relative values normalized to
the grey values of the sham group. *P,0.05 reveals an upregulation of the N-methyl-D-aspartate receptor type 1 and 2B subunits (NR1 and NR2B)
after sevoflurane anesthesia. No other receptor subunit was significantly altered. Example immunoblots are depicted in the insets. NR2A = NMDA
receptor type 2A subunit; a2-GABAA = a2 subunit of c-aminobutyric acid type A receptor; GluR1, GluR2/3, GluR4 = a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor subunits 1, 2/3, 4; GluR6/7 = kainate receptor subunit 6/7, b2-nAch =b2 subunit of nicotinic acetylcholine receptor.
doi:10.1371/journal.pone.0064732.g003
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effect in rats has been described, which is dependent on the
basolateral amygdala [8].
Data on the impact of anesthesia on synaptic plasticity is largely
limited to studies describing the effect of acute, in vitro application
of anesthetics during induction of LTP. To our knowledge, our
previous study [11] is the only one that investigated the impact of a
preceding anesthesia on synaptic plasticity so far. In this study, we
showed an enhanced hippocampal LTP 24 h after an isoflurane
anesthesia in mice. In the present study, the potentiation of
synaptic responses in CA1 neurons was not altered in mice which
underwent a sevoflurane anesthesia, which contrasts our recently
published data with isoflurane. Although sevoflurane and isoflur-
ane show a similar profile in view of their effects on voltage- and
ligandgated ion channels [13,14,46–48], differences in e.g. the
influence on the presynaptic glutamate release/reuptake [49] or
on protein kinase C activity [50] have been reported. As protein
kinase C activation is crucially involved in synaptic plasticity (for
review see e.g. [51]), these differences might explain the
discrepancy between isoflurane- and sevoflurane-induced medi-
um-term effects on LTP.
In summary, in the present study, we show that sevoflurane
anesthesia does not impair cognitive performance and CA1
hippocampal LTP formation in mice. Cognitive performance was
even improved, which could be explained by the elevation of
NR2B subunit expression in the hippocampus. Our data rather
indicate little or no role of sevoflurane anesthesia in contributing to
the development of cognitive impairment after anesthesia.
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